Who owns the BROMILASE trademark?

The BROMILASE trademark is owned by DIGI-PHARM S.r.l..

What class is the BROMILASE trademark registered in?

The BROMILASE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BROMILASE?

The USPTO serial number for BROMILASE is 79416394.

What is the registration number for BROMILASE?

BROMILASE is registered under USPTO registration number 8190778.

Sealvo

Home Search: BROMILASEBROMILASE #79416394

Back

Updated Oct 26, 2026·38 searches this week

View on USPTO TSDR Find similar marks

BRO

USPTO Trademark Record

REGISTERED

BROMILASE

SN 79416394·Reg 8190778·Filed Nov 14, 2024

Owner DIGI-PHARM S.r.l.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BROMILASE (Serial No. 79416394), Registration No. 8190778, is a registered US trademark filed on Nov 14, 2024 by DIGI-PHARM S.r.l.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: March 31, 2032

Mark Intelligence

BROMILASE (Reg. #8190778) is a registered US trademark that has been protecting its owner, DIGI-PHARM S.r.l., since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

Nov 14, 2024

SERIAL

79416394

REG#

8190778

REGISTERED

Mar 31, 2026

Filing Information

StatusREGISTERED

Filing DateNov 14, 2024

Serial Number79416394

Registration No.8190778

Registration DateMar 31, 2026

Status DateMar 31, 2026

Published for OppositionFeb 10, 2026

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Sep 24, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Sep 09, 2026

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Sep 09, 2026

FINAL DISPOSITION NOTICE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jul 23, 2026

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jul 06, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jul 05, 2026

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 30, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 31, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 31, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 10, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 10, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 04, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 15, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 06, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 05, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 05, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

Jul 26, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jul 05, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 05, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

ASSIGNED TO EXAMINER

Jun 02, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 23, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Apr 22, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 18, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 07, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 07, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 06, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by DIGI-PHARM S.r.l.

Additional USPTO filings from the same owner.

DIG

DIGI-PHARM

79425325

DIGI-PHARM S.r.l.

REGISTERED

Other Marks by Rebeccah Gan

Additional USPTO filings handled by the same attorney of record.

MUC

MUCELL

74642098

REGISTERED

MAX

MAX MARA

79237008

REGISTERED

XIM

XIMO

79241185

REGISTERED

PLU

PLUSHO POKETTOS

79434505

REGISTERED

BROMILASE

Run a conflict check

Other Marks by DIGI-PHARM S.r.l.

Other Marks by Rebeccah Gan

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company